Video Experimental Relacionado
Updated: Aug 2, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
691
La entrega de la próxima generación de inmunoterapias contra el cáncer con ARN
Theresa M Raimondo1, Kaelan Reed1, Dennis Shi1
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Cell
|April 14, 2023
Resumen
La inmunoterapia contra el cáncer ofrece beneficios, pero pocos pacientes responden. Las nanopartículas lipídicas de ARN son herramientas emergentes para la estimulación inmune, que son prometedoras para mejorar los tratamientos contra el cáncer.
Área de la Ciencia:
- En el campo de la oncología
- Inmunología
- Biotecnología
Sus antecedentes:
- La inmunoterapia contra el cáncer ha mostrado beneficios clínicos significativos, pero sufre de tasas de respuesta limitadas de los pacientes.
- Las inmunoterapias existentes son efectivas solo para un subconjunto de pacientes, lo que pone de relieve una necesidad crítica no satisfecha.
- Las nanopartículas lipídicas de ARN representan una nueva plataforma para modular el sistema inmunológico.
Objetivo del estudio:
- Revisar los avances recientes en las inmunoterapias contra el cáncer basadas en ARN.
- Explorar oportunidades para mejorar la eficacia de los tratamientos contra el cáncer basados en ARN.
- Discutir el potencial de las nanopartículas lipídicas de ARN en la inmunoterapia contra el cáncer.
Principales métodos:
- Revisión de la literatura de estudios recientes sobre la inmunoterapia del cáncer basada en el ARN.
- Análisis de los mecanismos de acción de las nanopartículas lipídicas de ARN en la estimulación inmune.
- Discusión de los retos actuales y las direcciones futuras en el campo.
Principales resultados:
- La inmunoterapia contra el cáncer ha producido importantes beneficios terapéuticos.
- Una parte significativa de los pacientes no se benefician de las inmunoterapias actuales.
- Las nanopartículas lipídicas de ARN son herramientas versátiles para la modulación inmune.
Conclusiones:
- Las terapias basadas en ARN, particularmente el uso de nanopartículas de lípidos, ofrecen una vía prometedora para mejorar la inmunoterapia contra el cáncer.
- La investigación adicional sobre la tecnología de nanopartículas de lípidos de ARN puede abordar las limitaciones actuales y ampliar las opciones de tratamiento.
- La optimización de la entrega de ARN y las estrategias de estimulación inmune es clave para mejorar las tasas de respuesta de los pacientes.
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
596
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
596
01:30Cancer Vaccines
456
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
456
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K